Data obtained from a study in 36 countries from all World Health Organisation (WHO)’s geographical regions and World Bank income groups have revealed an alarming lack of availability of essential medicines in the public sector. The study, which also included Nigeria, shows that this is driving patients to pay higher prices in […]
Mebendazol: A novel drug to be studied for metastatic Melanoma
Most patients with metastatic melanoma fail to respond to available therapies, the discovery of a viable investigational treatment with an established safety profile is a diehard need in oncology. The prohibitive costs and long lead times typically are two requirements to discover new cancer medicines. Effectively sidestepping these barriers, researchers at the NYU Cancer Institute […]
Production of Cancer Drug:: First Round Won by CIPLA Pharma
The Delhi High Court did not accede to the plea of Swiss Pharma Major ‘Hoffman La Roche’ seeking to restrain its rival ‘CIPLA Pharma’ from manufacturing and selling anti-Cancer Drug ‘Tarceva’ contending that it was a violation of their patent’s rights. Justice S.Ravindra Bhat passed an interim order to this effect which would permit ‘Cipla’ […]
The Do’s and Don’ts of Using Drugs Safely
Drugs are chemicals, each one composed of molecules. For the most part, molecules composing drugs are not the kinds that occur naturally in the body. They intrude into the body’s community of molecules and have a chemical influence on the way the body functions. According to medical records, many drugs influence the brain. They alter […]
NYSE:TARO Investor Alert: Deadline in Lawsuit against Taro Pharmaceutical Industries Ltd. upcoming
A deadline is coming up on December 26, 2016 in the lawsuit filed for certain investors in NYSE:TARO shares over alleged violations of securities laws by Taro Pharmaceutical Industries. Investors who purchased shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) have certain options and there are strict and short deadlines running. Deadline: December 26, 2016. NYSE:TARO […]
Taro Pharmaceutical Industries Ltd. (TARO) Investor Alert: Lawsuit alleges Misleading Statements
An investor in NYSE:TARO shares filed a lawsuit over alleged violations of Federal Securities Laws by Taro Pharmaceutical Industries Ltd.. Investors who purchased shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) have certain options and for certain investors are short and strict deadlines running. Deadline: December 26, 2016. NYSE:TARO investors should contact the Shareholders Foundation at […]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 18
- Next Page »